EconPapers    
Economics at your fingertips  
 

Geopolitics and Financial Profitability, the Big Pharmaceutical Corporations

Alicia Girón

Journal of Economic Issues, 2022, vol. 56, issue 2, 562-569

Abstract: The pandemic evidenced the struggle for financial profitability of Big Pharmaceutical Corporations, inequality between countries, and within nations, resulting from more than fifty years of stabilization policies, where monetary and fiscal policies have subsumed themselves to the institutional investors’ interests. In the face of lockdown measures and the attempt to return to “normality,” central banks, as lenders of last resort, abandoned financial restriction policies to give way to fiscal policies and promoted a soft readjustment through credit expansion and accelerated public debt looking to recover economic growth in a “fast track.” Proof of this is the worldwide recovery of GDP growth rates but, despite having a rapid recovery, they showed an uncertain scenario in the short and medium terms, accompanied by financial exuberance in stock market indicators at the international level. The focus of this paper will be on demonstrating the profits of pharmaceutical companies, a business that, in the long term, intensified due to the new mutations that SARS-CoV-2 has had during the current situation. It is also important the unequal vaccine access by country and by region. Concluding with a reflection on the struggle between an economy for life and financialized economy.

Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/00213624.2022.2065853 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:mes:jeciss:v:56:y:2022:i:2:p:562-569

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/MJEI20

DOI: 10.1080/00213624.2022.2065853

Access Statistics for this article

More articles in Journal of Economic Issues from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().

 
Page updated 2025-03-19
Handle: RePEc:mes:jeciss:v:56:y:2022:i:2:p:562-569